chronic
obstruct
pulmonari
diseas
copd
major
public
health
problem
preval
mortal
increas
throughout
world
includ
asiapacif
region
arrest
worldwid
trend
global
initi
chronic
obstruct
lung
diseas
gold
expert
panel
global
strategi
diagnosi
manag
prevent
copd
publish
base
recent
publish
clinic
trial
gold
statement
updat
asiapacif
copd
roundtabl
group
taskforc
expert
respirologist
asiapacif
region
recent
formul
consensu
statement
implement
gold
strategi
copd
asiapacif
region
key
issu
identifi
copd
roundtabl
group
comment
access
spirometri
diagnosi
copd
could
suspect
basi
histori
symptom
physic
sign
ii
inhal
bronchodil
prefer
regular
treatment
copd
region
oral
bronchodil
may
consid
cost
inhal
bronchodil
barrier
treatment
iii
use
meter
dose
inhal
spacer
place
nebul
recommend
treatment
acut
airflow
obstruct
patient
copd
iv
influenza
vaccin
recommend
patient
copd
commun
high
likelihood
sever
acut
respitori
syndrom
v
simplifi
pulmonari
rehabilit
programm
establish
area
comprehens
programm
unavail
physic
exercis
train
educ
smoke
cessat
core
element
rehabilit
program
summari
copd
roundtabl
group
support
implement
gold
strategi
diagnosi
manag
prevent
copd
asiapacif
region
subject
addit
modif
guidelin
suggest
chronic
obstruct
pulmonari
diseas
copd
major
public
health
problem
throughout
world
world
health
organ
world
bank
studi
estim
worldwid
preval
copd
men
women
copd
estim
sixth
common
caus
death
global
twelfth
common
caus
burden
diseas
worldwid
furthermor
copd
expect
increas
preval
mortal
come
decad
exampl
four
lead
caus
death
usa
copd
one
continu
increas
preval
copd
also
project
fifth
greatest
caus
worldwid
burden
diseas
third
common
caus
death
intern
copd
associ
huge
econom
cost
uk
exampl
copd
account
work
day
lost
usa
estim
annual
cost
copd
us
billion
rel
littl
known
preval
morbid
mortal
copd
develop
countri
includ
asiapacif
region
recent
studi
thailand
estim
preval
copd
per
peopl
risk
smoker
age
year
estim
base
number
peopl
hospit
copd
therefor
repres
preval
moder
sever
diseas
whoworld
bank
studi
estim
preval
copd
differ
area
world
use
inform
expert
opinion
extrapol
compar
region
publish
data
lack
suggest
preval
copd
china
male
femal
estim
challeng
recent
report
overal
copd
preval
per
peopl
age
year
three
region
china
whoworld
bank
studi
also
estim
copd
preval
male
femal
asia
island
amalgam
countri
island
state
asiapacif
region
furthermor
data
studi
use
extrapol
copd
preval
figur
per
peopl
entir
asian
popul
estim
necessarili
base
actual
epidemiolog
data
provid
reliabl
inform
precis
preval
copd
asiapacif
region
turn
mean
govern
unawar
region
econom
human
impact
copd
therefor
unabl
plan
effect
strategi
reduc
burden
diseas
largescal
populationbas
epidemiolog
studi
logist
difficult
expens
conduct
altern
method
assess
copd
preval
make
use
wellvalid
computer
tool
predict
preval
basi
local
copd
risk
factor
data
preval
smoke
exposur
biomass
fuel
air
pollut
highrisk
occup
etc
shown
overal
preval
clinic
signific
copd
amongst
adult
year
old
asiapacif
region
approxim
data
suggest
copd
signific
problem
region
previous
realis
furthermor
trend
risk
factor
increas
incid
smoke
greater
longev
associ
increas
risk
succumb
chronic
diseas
copd
increas
exposur
environment
pollut
suggest
preval
copd
asiapacif
region
like
increas
come
year
intern
group
copd
expert
met
discuss
develop
global
initi
chronic
obstruct
lung
diseas
gold
cosponsor
us
nation
institut
health
heart
lung
blood
institut
nhlbi
gold
expert
panel
consist
health
profession
around
world
expertis
respiratori
medicin
epidemiolog
socioeconom
public
health
health
educ
model
initi
global
initi
asthma
gina
intern
strategi
develop
comprehens
evidencebas
guidelin
asthma
control
manag
use
committe
expert
gold
expert
panel
agre
object
gold
increas
awar
copd
amongst
govern
public
health
offici
healthcar
worker
gener
public
improv
prevent
manag
diseas
decreas
copd
morbid
mortal
encourag
new
research
diseas
gold
expert
panel
conduct
workshop
review
exist
copd
guidelin
advanc
understand
diseas
ultim
aim
prepar
consensu
guidelin
documentglob
strategi
diagnosi
manag
prevent
copd
publish
full
workshop
report
execut
summari
form
earli
updat
gold
guidelin
base
clinic
research
publish
june
march
impact
manag
copd
publish
juli
report
present
evidencebas
guidelin
copd
diagnosi
manag
importantli
includ
grade
b
c
weight
scientif
evid
support
recommend
gold
strategi
present
copd
manag
plan
divid
four
compon
assess
monitor
diseas
ii
reduct
risk
factor
iii
manag
stabl
copd
iv
manag
exacerb
inform
recommend
present
gold
report
base
bestvalid
current
concept
copd
pathogenesi
avail
evid
appropri
manag
prevent
strategi
content
report
develop
expert
copd
research
clinic
manag
extens
review
expert
scientif
societi
nhlbi
public
gold
guidelin
audit
implement
assess
impact
programm
outcom
updat
gold
guidelin
includ
follow
chang
classif
system
modifi
mild
ii
moder
iii
sever
iv
sever
ii
moder
sever
copd
use
regular
treatment
longact
bronchodil
includ
tiotropium
rather
shortact
bronchodil
recommend
evid
level
iii
inhal
glucocorticosteroid
recommend
patient
copd
sever
iii
frequent
exacerb
evid
level
iv
rehabilit
programm
month
durat
evid
level
b
v
nurseadminist
home
care
repres
effect
practic
altern
hospit
select
patient
exacerb
copd
without
acidot
respiratori
failur
gold
recommend
intend
univers
applic
expert
panel
drew
attent
possibl
difficulti
implement
gold
recommend
develop
countri
thu
gold
expert
panel
note
reproduc
inexpens
exercisetest
methodolog
suitabl
use
develop
countri
need
evalu
use
encourag
spiromet
need
develop
ensur
econom
accur
perform
rel
untrain
oper
administ
test
method
strategi
implement
copd
manag
program
develop
countri
requir
special
attent
thu
gold
expert
panel
acknowledg
aspect
gold
guidelin
may
requir
amend
ensur
relev
applic
use
develop
countri
asiapacif
region
task
taken
asiapacif
copd
roundtabl
group
copd
roundtabl
group
taskforc
expert
respirologist
asiapacif
region
met
time
per
year
sinc
juli
copd
roundtabl
group
support
asiapacif
societi
respirolog
apsr
support
educ
grant
boehring
ingelheim
pfizer
main
object
copd
roundtabl
group
increas
awar
copd
region
ii
assess
region
relev
applic
gold
guidelin
facilit
implement
iii
identifi
copdrel
problem
specif
region
discuss
resolut
iv
stimul
region
collabor
research
copd
note
howev
one
main
reason
establish
copd
roundtabl
group
facilit
region
implement
gold
guidelin
end
roundtabl
group
develop
consensu
statement
implement
gold
strategi
copd
asiapacif
region
relev
practic
gold
recommend
region
consid
copd
roundtabl
group
sever
meet
review
process
roundtabl
member
focus
implic
implement
gold
strategi
countri
take
account
local
publish
data
member
experi
copd
diagnosi
manag
prevent
region
basi
deliber
copd
roundtabl
group
conclud
implement
gold
recommend
would
use
asiapacif
region
particular
strength
gold
strategi
identifi
roundtabl
includ
emphasi
need
spirometri
diagnosi
assess
copd
ii
inclus
diseas
sever
classif
recogn
import
intervent
presymptomat
diseas
stage
copd
roundtabl
group
also
endors
gold
guidelin
smoke
cessat
view
immens
burden
smokingrel
copd
asiapacif
region
believ
greater
effort
achiev
smoke
prevent
cessat
encourag
part
world
addit
copd
roundtabl
group
identifi
aspect
gold
guidelin
requir
amend
suit
need
region
amend
discuss
gold
document
unequivoc
identifi
spirometri
gold
standard
diagnosi
assess
copd
reproduc
standard
object
way
measur
airflow
limit
specif
fev
fvc
ratio
togeth
postbronchodil
fev
predict
confirm
presenc
airflow
limit
fulli
revers
gold
also
state
health
care
worker
involv
diagnosi
manag
copd
patient
access
spirometri
copd
roundtabl
group
fulli
support
recommend
encourag
use
spirometri
diagnosi
assess
copd
patient
asiapacif
region
howev
roundtabl
group
also
note
number
reason
eg
cost
inaccess
lack
awar
lack
technic
knowledg
etc
spirometri
unavail
larg
number
patient
mani
asian
countri
gold
guidelin
state
spirometri
unavail
diagnosi
copd
made
use
avail
tool
therefor
asiapacif
region
copd
roundtabl
group
recommend
addit
follow
statement
gold
guidelin
relat
diagnosi
assess
copd
access
spirometri
diagnosi
copd
could
suspect
basi
histori
symptom
physic
sign
spirometri
avail
peak
flow
measur
use
exclud
asthma
diagnos
copd
forc
expiratori
time
fet
time
taken
individu
forc
exhal
open
mouth
total
lung
capac
airflow
becom
inaud
time
taken
exhal
record
stopwatch
abnorm
prolong
good
guid
presenc
fev
fvc
ratio
ie
obstruct
diseas
chest
xray
recommend
diagnos
copd
use
exclud
common
diseas
give
rise
airway
obstruct
eg
tuberculosi
bronchiectasi
lung
cancer
etc
littl
correl
peak
flow
measur
symptom
longitudin
studi
copd
patient
copd
patient
improv
symptom
qualiti
life
without
improv
lung
function
group
recommend
use
serial
measur
peak
flow
assess
monitor
respons
therapi
mrc
dyspnoea
scale
use
diagnosi
copd
function
scale
use
assess
short
breath
disabl
assist
evalu
diseas
sever
gold
recommend
inhal
bronchodil
prefer
option
symptomat
manag
stabl
copd
either
regular
treatment
asneed
basi
bronchodil
therapi
prevent
symptom
reduc
sever
modifi
declin
lung
function
copd
inhal
bronchodil
therapi
prefer
oral
therapi
lower
dose
need
achiev
therapeut
respons
advers
effect
less
like
occur
resolv
rapidli
treatment
withdraw
copd
roundtabl
group
support
promot
inhal
therapi
prefer
rout
bronchodil
deliveri
copd
patient
region
howev
roundtabl
group
also
note
asiapacif
set
cost
therapi
reimburs
patient
limit
financi
resourc
oral
bronchodil
treatment
may
less
expens
therefor
appropri
altern
inhal
therapi
emphasis
inhal
bronchodil
remain
prefer
option
state
gold
copd
roundtabl
group
recommend
addit
follow
statement
gold
guidelin
relat
use
bronchodil
treatment
stabl
copd
wherev
possibl
copd
patient
receiv
bronchodil
therapi
via
inhal
rout
howev
oral
bronchodil
b
agonist
theophyllin
may
appropri
cost
inhal
bronchodil
barrier
treatment
gold
report
note
treatment
given
inhal
rout
attent
effect
drug
deliveri
train
inhal
techniqu
essenti
copd
patient
may
problem
effect
coordin
find
harder
use
simpl
meter
dose
inhal
mdi
healthi
volunt
younger
asthmat
essenti
ensur
inhal
techniqu
correct
recheck
visit
patient
prescrib
drug
use
mdi
troubl
master
inhal
techniqu
attempt
use
spacer
mdi
copd
roundtabl
group
note
use
spacer
result
effici
deliveri
bronchodil
lung
compar
use
mdi
alon
particularli
patient
master
correct
inhal
techniqu
furthermor
approach
effect
nebul
drug
deliveri
patient
taught
use
spacer
plu
mdi
correctli
patient
altern
inhal
devic
may
also
tri
optim
benefit
inhal
therapi
exampl
dri
powder
inhal
dpi
breath
activ
requir
level
handandmouth
coordin
mdi
copd
patient
may
find
easier
use
reason
copd
roundtabl
group
recommend
addit
follow
statement
gold
guidelin
relat
use
bronchodil
treatment
stabl
copd
patient
difficulti
master
inhal
techniqu
mdi
tri
use
spacer
mdi
differ
type
spacer
inhal
devic
experi
attempt
identifi
devic
patient
use
easili
effect
inhal
techniqu
patient
requir
train
use
spacer
effect
approach
conveni
recommend
treatment
nebul
nebul
may
avail
mani
copd
patient
asiapacif
region
expens
requir
setup
power
sourc
fill
nebul
solut
furthermor
area
affect
sever
acut
respiratori
syndrom
sar
thought
risk
transmiss
viru
may
reduc
use
spacer
devic
asiapacif
region
sever
affect
epidem
sar
caus
new
coronaviru
farreach
health
societ
econom
cost
epidem
peak
februari
may
epidem
sar
brought
control
warn
absenc
vaccin
cure
possibl
season
recurr
rule
import
sar
differenti
respiratori
diseas
particularli
trigger
mimic
acut
exacerb
copd
current
gold
standard
diagnosi
usual
encompass
suspicion
isol
empir
use
antibiot
support
treatment
sar
thought
transmit
via
droplet
close
contact
howev
airborn
mode
transmiss
exclud
reason
recommend
nebul
treatment
patient
copd
avoid
use
spacer
devic
may
help
reduc
risk
use
mdi
spacer
place
nebul
recommend
treatment
acut
airflow
obstruct
patient
copd
attempt
reduc
risk
droplet
transmiss
respiratori
infect
sar
sar
consid
differenti
diagnosi
acut
exacerb
copd
sar
suspect
patient
triag
accordingli
recommend
bronchodil
treatment
delay
deni
patient
copd
treat
patient
experienc
acut
exacerb
import
ensur
bronchodil
dosag
adequ
titrat
frequent
interv
base
patient
respons
use
spacer
instead
nebul
recommend
appropri
ventilatori
support
delay
deni
patient
copd
burden
suspect
sar
reduc
influenza
vaccin
copd
patient
gold
expert
panel
cite
categori
evid
influenza
vaccin
reduc
seriou
ill
death
copd
patient
approxim
light
evid
gold
recommend
vaccin
influenza
patient
copd
vaccin
contain
kill
live
inactiv
virus
use
sinc
shown
effect
elderli
patient
copd
gold
guidelin
add
influenza
strain
adjust
annual
appropri
effect
given
autumn
twice
autumn
winter
year
copd
roundtabl
group
note
influenza
vaccin
routin
offer
copd
patient
asia
given
pulmonologist
respons
patient
request
furthermor
review
literatur
show
knowledg
gap
respect
use
influenza
vaccin
region
particularli
patient
copd
earli
deliber
reserv
regard
vaccin
copd
patient
howev
reevalu
context
new
inform
recent
clinic
trial
efficaci
influenza
vaccin
sar
epidem
within
asiapacif
region
consider
mind
copd
roundtabl
group
recommend
addit
follow
statement
gold
guidelin
relat
influenza
vaccin
patient
copd
influenza
vaccin
highli
recommend
copd
patient
within
asiapacif
region
could
recurr
sar
mimic
clinic
present
influenza
patient
vaccin
month
prior
anticip
peak
incid
influenza
copd
roundtabl
group
recommend
vaccin
patient
copd
commun
high
likelihood
sar
remain
issu
regard
implement
influenza
vaccin
copd
patient
asiapacif
region
follow
reason
low
surveil
data
tropic
countri
ii
appar
lack
bimod
season
tropic
countri
iii
uncertainti
appropri
frequenc
time
vaccin
iv
presenc
two
potenti
vaccin
formul
coincid
influenza
strain
emerg
februari
septemb
v
limit
efficaci
data
vaccin
tropic
countri
vi
lack
costeffect
costsav
studi
countri
bimod
peak
rel
lack
season
influenza
infect
choic
vaccin
left
physician
gold
list
main
goal
pulmonari
rehabilit
programm
patient
copd
reduct
symptom
improv
qualiti
life
increas
physic
emot
particip
everyday
activ
goal
achiev
attend
problem
exercis
decondit
social
isol
depressionoth
mood
disturb
muscl
wast
weight
loss
sinc
problem
particularli
affect
patient
stage
ii
moder
stage
iii
sever
stage
iv
sever
copd
gold
recommend
patient
subgroup
enrol
pulmonari
rehabilit
programm
howev
gold
guidelin
also
point
categori
evid
indic
copd
patient
stage
diseas
benefit
term
exercis
toler
symptom
dyspnoea
fatigu
exercis
train
programm
note
gold
document
pulmonari
rehabilit
care
evalu
larg
number
clinic
trial
yield
categori
evid
pulmonari
rehabilit
improv
exercis
capac
reduc
perceiv
intens
breathless
improv
healthrel
qualiti
life
reduc
number
hospit
day
hospit
reduc
anxieti
depress
associ
copd
also
categori
b
evid
pulmonari
rehabilit
improv
arm
function
strength
endur
train
upper
limb
provid
benefit
extend
well
beyond
immedi
period
train
provid
home
exercis
train
continu
programm
end
improv
surviv
patient
copd
gold
guidelin
also
note
pulmonari
rehabilit
programm
ideal
involv
sever
type
health
profession
howev
signific
benefit
also
attain
limit
personnel
long
healthcar
profession
concern
awar
need
individu
patient
updat
gold
guidelin
recommend
durat
month
pulmonari
rehabilit
comprehens
pulmonari
rehabilit
programm
includ
exercis
train
assess
session
bicycl
ergometri
treadmil
exercis
walk
test
etc
peak
oxygen
consumpt
symptom
interven
daili
weekli
basi
nutrit
counsel
nutrit
state
import
determin
symptom
disabl
prognosi
copd
overweight
underweight
patient
potenti
problem
howev
nutrit
therapi
without
accompani
exercis
regimen
may
help
educ
educ
patient
compon
pulmonari
rehabilit
programm
specif
contribut
improv
seen
pulmonari
rehabilit
remain
unclear
gold
guidelin
also
emphas
baselin
outcom
assess
made
particip
pulmonari
rehabilit
programm
individu
gain
quantifi
appropri
area
target
improv
assess
includ
histori
physic
examin
preand
postbronchodil
spirometri
exercis
capac
health
statu
impact
breathless
inspiratori
expiratori
muscl
strength
possibl
lower
limb
strength
patient
muscl
wast
copd
roundtabl
group
recogn
pulmonari
rehabilit
one
effect
manag
strategi
patient
copd
therefor
use
benefit
promot
copd
patient
healthcar
profession
fund
agenc
govern
region
unfortun
comprehens
pulmonari
rehabilit
programm
describ
gold
beyond
mean
mani
asian
healthcar
system
therefor
unavail
patient
region
inde
difficulti
provid
pulmonari
rehabilit
programm
develop
countri
reduc
resourc
avail
healthcar
may
better
appreci
consid
develop
countri
canada
copd
popul
per
annum
access
pulmonari
rehabilit
programm
physician
asiapacif
region
unabl
refer
copd
patient
establish
pulmonari
rehabilit
programm
unlik
abl
organ
complex
multidisciplinari
type
programm
describ
literatur
howev
may
abl
organ
next
best
altern
less
complic
programm
includ
import
compon
pulmonari
rehabilit
minimum
element
pulmonari
rehabilit
could
made
avail
simplifi
programm
involv
limit
number
type
healthcar
profession
includ
basic
exercis
test
exampl
walk
distanc
test
ii
regular
daili
possibl
exercis
exampl
walk
symptomlimit
maximum
rest
continu
walk
min
exercis
complet
iii
educ
patient
minim
exposur
copd
risk
factor
smoke
indoor
air
pollut
due
biomass
fuel
occup
hazard
measur
could
includ
simplifi
pulmonari
rehabilit
programm
would
expect
benefit
copd
patient
access
intens
complet
programm
point
pertin
note
pulmonari
rehabilit
programm
conduct
home
associ
benefit
copd
patient
consider
mind
copd
roundtabl
group
recommend
addit
follow
statement
gold
guidelin
relat
pulmonari
rehabilit
patient
copd
although
limit
evid
within
region
simplifi
pulmonari
rehabilit
program
includ
crucial
element
regular
exercis
train
patient
educ
found
workabl
recommend
exercis
train
program
involv
simpl
structur
element
baselin
walk
test
determin
workload
requir
follow
regular
session
walk
min
ideal
upper
limb
exercis
pivot
success
pulmonari
rehabilit
program
patient
educ
initi
may
undertaken
train
physiotherapist
improv
patient
awar
import
smoke
cessat
manag
copd
initi
aid
enhanc
patient
cooper
improv
rapport
patient
physiotherapist
gold
strategi
diagnosi
manag
prevent
copd
import
initi
relev
use
asiapacif
region
copd
roundtabl
group
agre
content
recommend
gold
strategi
support
implement
programm
mean
help
prevent
copd
improv
diagnosi
manag
diseas
region
respect
view
copd
roundtabl
group
diverg
gold
guidelin
express
specif
modif
outlin
text
note
copd
roundtabl
group
statement
gold
guidelin
repres
consensu
view
member
group
public
howev
statement
present
work
document
discussionfeedback
octob
meet
apsr
taipei
clarif
key
messag
articul
copd
roundtabl
group
may
warrant
avoid
misinterpret
regard
spirometri
roundtabl
group
keen
emphas
key
role
tool
diagnos
assess
copd
press
need
greater
avail
spiromet
region
roundtabl
group
urg
gold
recommend
issu
use
mount
pressur
region
govern
health
fund
agenc
financ
wider
access
spirometri
region
also
manufactur
provid
cheap
effici
spiromet
howev
econom
consider
barrier
use
spirometri
asian
countri
other
includ
lack
demand
forrecognit
need
spirometr
test
patient
healthcar
profession
health
administr
policymak
lack
technic
knowledg
expertis
use
spiromet
inappropri
emphasi
report
diagnos
manag
symptom
oppos
lung
function
patient
copd
reason
vital
note
copd
roundtabl
group
recommend
diagnosi
copd
suspect
basi
symptom
physic
sign
histori
spirometri
unavail
import
implic
statement
diagnosi
copd
repeat
peak
expiratori
flow
measur
chest
xray
appear
circumst
recommend
similarli
none
recommend
made
copd
roundtabl
group
interpret
contraven
gold
recommend
roundtabl
group
note
inhal
rout
prefer
mean
bronchodil
deliveri
copd
patient
oral
bronchodil
use
afford
inhal
altern
patient
similarli
roundtabl
group
agre
enrol
copd
patient
standard
pulmonari
rehabilit
programm
prefer
option
one
promot
much
possibl
suggest
particip
simplifi
programm
better
pulmonari
rehabilit
respect
experi
spacer
use
nebul
also
consist
discuss
bronchodil
therapi
present
full
workshop
report
gold
strategi
approach
tri
patient
unabl
master
inhal
techniqu
mdi
health
profession
care
copd
patient
take
time
educ
patient
correct
inhal
techniqu
check
correct
techniqu
followup
consult
countri
philippin
high
rate
nebul
use
prompt
copd
roundtabl
group
includ
specif
endors
use
spacer
devic
resort
nebul
final
gold
recommend
influenza
vaccin
patient
copd
light
recent
sar
epidem
copd
roundtabl
group
support
recommend
howev
limit
evid
regard
influenza
vaccin
within
asiapacif
region
roundtabl
group
suggest
countri
lack
season
influenza
choic
vaccin
left
physician
adher
copd
guidelin
shown
improv
clinic
outcom
also
lower
healthcar
cost
us
teach
hospit
set
find
studi
conduct
develop
countri
automat
extrapol
healthcar
system
develop
countri
copd
roundtabl
group
consid
implement
gold
strategi
prevent
diagnosi
manag
copd
asiapacif
region
would
confer
similar
type
clinic
econom
benefit
hope
addit
modif
gold
guidelin
suggest
copd
roundtabl
group
enhanc
applic
use
guidelin
region
final
copd
roundtabl
group
acknowledg
need
region
studi
evalu
consensu
recommend
clinic
data
exampl
efficaci
pulmonari
rehabilit
programm
diagnosi
copd
without
spirometri
lend
support
enabl
refin
consensu
statement
